Skip to main content
Top

Current Cardiology Reports

Issue 10/2018

Content (20 Articles)

Treatment of Bifurcation Lesions: Has DK Crush“ed” the Competition?

  • Interventional Cardiology (SR Bailey, Section Editor)

Bryce S. Lynn, James B. Hermiller

Drug-Coated Balloons: Hope or Hot Air: Update on the Role of Coronary DCB

  • Interventional Cardiology (SR Bailey, Section Editor)

Rafael A. Meneguz-Moreno, J. Ribamar Costa Jr, Alexandre Abizaid

TAVR Vs. SAVR in Intermediate-Risk Patients: What Influences Our Choice of Therapy

  • Interventional Cardiology (SR Bailey, Section Editor)

Sasha Still, Molly Szerlip, Michael Mack

Heart Transplantation and Mechanical Circulatory Support in Adults with Congenital Heart Disease

  • Congenital Heart Disease (RA Krasuski, Section Editor)

John D. Serfas, Priyesh A. Patel, Richard A. Krasuski

It Is Not Taboo: Addressing Sexual Function in Adults with Congenital Heart Disease

  • Congenital Heart Disease (RA Krasuski, Section Editor)

Sihong Huang, Stephen C. Cook

Genetics of Dilated Cardiomyopathy: Clinical Implications

  • Myocardial Disease (A Abbate, Section Editor)

A. Paldino, G. De Angelis, M. Merlo, M. Gigli, M. Dal Ferro, G. M. Severini, L. Mestroni, G. Sinagra

The Biological Mechanisms of Action of Cardiac Progenitor Cell Therapy

  • Myocardial Disease (A Abbate, Section Editor)

Francesca Pagano, Vittorio Picchio, Francesco Angelini, Alessandra Iaccarino, Mariangela Peruzzi, Elena Cavarretta, Giuseppe Biondi-Zoccai, Sebastiano Sciarretta, Elena De Falco, Isotta Chimenti, Giacomo Frati

Treatment of Diabetes in Patients with Heart Failure

  • Myocardial Disease (A Abbate, Section Editor)

Christa D. Bowes, Lillian F. Lien, Javed Butler

Circulatory Mechanotherapeutics: Moving with the Force

  • Heart Failure (HJ Eisen, Section Editor)

Pablo Huang Zhang, J. Yasha Kresh

ECMO and Short-term Support for Cardiogenic Shock in Heart Failure

  • Heart Failure (HJ Eisen, Section Editor)

Mathew Jose Chakaramakkil, Cumaraswamy Sivathasan

Is Bioprosthetic Valve Fracture Beneficial for Patients with Larger Surgical Valves Undergoing Valve in Valve TAVR?

  • New Therapies for Cardiovascular Disease (AA Bavry, Section Editor)

Adnan K. Chhatriwalla, John T. Saxon, David J. Cohen, Keith B. Allen

Ulnar Artery Catheterization: Is This Our Second Access Site or Is It Still Femoral?

  • New Therapies for Cardiovascular Disease (AA Bavry, Section Editor)

Mladen I. Vidovich

Venous Thromboembolism and Cancer

  • Cardio-Oncology (SA Francis and RB Morgan, Section Editors)

Alec A. Schmaier, Paurush Ambesh, Umberto Campia

Pericardial Disease Associated with Malignancy

  • Cardio-Oncology (SA Francis and RB Morgan, Section Editors)

Ryan Schusler, Shari L. Meyerson

Does Left Atrial Appendage Amputation During Routine Cardiac Surgery Reduce Future Atrial Fibrillation and Stroke?

  • Open Access
  • Invasive Electrophysiology and Pacing (EK Heist, Section Editor)

Helena Domínguez, Christoffer Valdorff Madsen, Oliver Nøhr Hjorth Westh, Peter Appel Pallesen, Christian Lildal Carrranza, Akhmadjon Irmukhamedov, Jesper Park-Hansen

Which Lipids Should Be Analyzed for Diagnostic Workup and Follow-up of Patients with Hyperlipidemias?

  • Lipid Abnormalities and Cardiovascular Prevention (G De Backer, Section Editor)

Michel R. Langlois, Børge G. Nordestgaard

Ruptured Sinus of Valsalva Aneurysm and Gerbode Defects: Patient and Procedural Selection: the Key to Optimising Outcomes

  • Structural Heart Disease (RJ Siegel and NC Wunderlich, Section Editors)

Colm R. Breatnach, Kevin P. Walsh

The Healthy Health Care Workplace: a Competitive Advantage

  • Public Health Policy (E Klodas, Section Editor)

Michael D. Parkinson

Infective Endocarditis: Update on Epidemiology, Outcomes, and Management

  • Valvular Heart Disease (TL Kiefer, Section Editor)

Logan L. Vincent, Catherine M. Otto

Assessment of Left Atrial Function by Echocardiography: Novel Insights

  • Echocardiography (JM Gardin and AH Waller, Section Editors)

Brian D. Hoit

Next-generation MRI contrast agents: preparing the field (Link opens in a new window)

New MRI contrast agents are reshaping diagnostic imaging, promising lower gadolinium exposure amid evolving practice guidelines. How can you optimise contrast selection, dosing, and patient care in this rapidly advancing field?

This content is intended for healthcare professionals outside of the UK.

Independent Medical Education Grant:
  • Bayer HealthCare Pharmaceuticals Inc.
Learn more Link opens in a new window
Image Credits
Abstract graphic of layered, concentric circular shapes in bright green, pink, blue, and purple on a dark blue background. The rings and segments form a complex radial pattern without text/© Springer Health+ IME